CD4 and neoplasm: Additionally, IL-17, a proinflammatory cytokine primarily produced by CD4+ Th17 cells, exerts an antitumor effect by recruiting CD4+ T, CD8+ T, and NK cells to the tumor site, enhancing NK cell activity 47.